Recent SUPN News
- Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree • GlobeNewswire Inc. • 09/24/2024 11:30:33 AM
- Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit • GlobeNewswire Inc. • 09/19/2024 08:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 09:00:12 PM
- Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference • GlobeNewswire Inc. • 08/28/2024 08:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 11:03:01 AM
- Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA • GlobeNewswire Inc. • 08/19/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:18:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:16:00 PM
- Supernus Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:06:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 08:16:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:58:35 PM
- Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device • GlobeNewswire Inc. • 08/01/2024 08:30:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:19:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/31/2024 08:41:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 08:02:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/29/2024 08:08:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/24/2024 08:48:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:20:54 PM
- Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 • GlobeNewswire Inc. • 07/23/2024 08:13:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 08:24:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/19/2024 08:28:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:18:19 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM